Matches in Wikidata for { <http://www.wikidata.org/entity/Q92945145> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92945145 description "article scientifique publié en 2019" @default.
- Q92945145 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92945145 description "scientific article published on 13 May 2019" @default.
- Q92945145 description "wetenschappelijk artikel" @default.
- Q92945145 description "наукова стаття, опублікована 13 травня 2019" @default.
- Q92945145 name "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 name "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 type Item @default.
- Q92945145 label "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 label "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 prefLabel "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 prefLabel "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 P1433 Q92945145-C8E069D0-50E8-4639-B04B-40B9FB40F2C8 @default.
- Q92945145 P1476 Q92945145-8B761B73-91DF-421F-8973-8A81C618E269 @default.
- Q92945145 P2093 Q92945145-5D0BCBD5-FF4D-478C-AE42-13E0AE47D073 @default.
- Q92945145 P2093 Q92945145-8B34A89A-BFD5-4B0E-84FA-8C3D24904F4B @default.
- Q92945145 P2093 Q92945145-8CCBD8BA-7D71-4AA4-955A-83E96309B9AE @default.
- Q92945145 P304 Q92945145-F8D7ABD6-605E-4D91-9D6B-EC0B311BFB5C @default.
- Q92945145 P31 Q92945145-D7DE84C5-2336-49ED-B09D-8DF9E4489D16 @default.
- Q92945145 P356 Q92945145-74A44605-9F27-4932-A6A6-7F8C2D475592 @default.
- Q92945145 P433 Q92945145-538B1156-5B4A-4E7B-866A-63D116EB574E @default.
- Q92945145 P478 Q92945145-E551B571-E84E-43DC-BD07-31B5970D881D @default.
- Q92945145 P50 Q92945145-B45177BB-F16E-4319-962C-8182F59E92A3 @default.
- Q92945145 P50 Q92945145-D64D0657-3445-4A38-83BC-AEF7216288CB @default.
- Q92945145 P577 Q92945145-F82A5F0E-4A28-4863-AE45-06E6A76C7B79 @default.
- Q92945145 P698 Q92945145-2CE266D0-C0D1-4DC4-A410-977D70F77D66 @default.
- Q92945145 P921 Q92945145-2521344A-B979-4D11-BD5D-729FE9E29ADE @default.
- Q92945145 P921 Q92945145-8CE614FF-CE42-46E5-88E7-05C3F47E8E35 @default.
- Q92945145 P921 Q92945145-C623F6E1-4EFC-4E9F-A54F-81268BA6D539 @default.
- Q92945145 P356 J.CLML.2019.05.008 @default.
- Q92945145 P698 31227358 @default.
- Q92945145 P1433 Q5133774 @default.
- Q92945145 P1476 "Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia" @default.
- Q92945145 P2093 "Anthony S Stein" @default.
- Q92945145 P2093 "Thorsten Graef" @default.
- Q92945145 P2093 "Ying Luan" @default.
- Q92945145 P304 "509-515.e1" @default.
- Q92945145 P31 Q13442814 @default.
- Q92945145 P356 "10.1016/J.CLML.2019.05.008" @default.
- Q92945145 P433 "8" @default.
- Q92945145 P478 "19" @default.
- Q92945145 P50 Q57003249 @default.
- Q92945145 P50 Q60320900 @default.
- Q92945145 P577 "2019-05-13T00:00:00Z" @default.
- Q92945145 P698 "31227358" @default.
- Q92945145 P921 Q180983 @default.
- Q92945145 P921 Q264118 @default.
- Q92945145 P921 Q5984881 @default.